Paul Hastings’ eight-partner appellate team won success in intellectual property, immigration and securities matters last year. But the firm’s work fending off employment class actions for its corporate clients was particularly noteworthy.
In a high-profile labor case, Neal Mollen, co-chairman of the firm’s appellate practice, scored a major victory for the pharmaceutical industry before the U.S. Supreme Court in Christopher v. GlaxoSmithKline. Drug companies had long viewed their thousands of sales representatives as independent contractors and didn’t pay them overtime. That practice fell into doubt when Novartis A.G. in 2010 lost a class action in the U.S. Court of Appeals for the Second Circuit brought by sales reps seeking overtime pay and settled for $99 million.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
